Condition: Systemic Sclerosis (SSc) · Sponsor: Robyn T. Domsic, MD, MPH
The purpose of this study it to test the efficacy of a wearable device to improve symptom management and maximize qualify of life in systemic Sclerosis (SSc) patients in a randomized trial. Specifically, we will evaluate if the Apollo Neuro device may improve the two specific symptoms highest ranked by patients as affecting qualify of life (fatigue, Raynaud phenomenon) as co-primary outcomes.
This description comes directly from the study's public registry record.
Maureen M Laffoon, BS · 412-648-7871 · laffoonm@pitt.edu
Robyn T Domsic, MD · 412-647-6700 · rtd4@pitt.edu
Always discuss trial participation with your own doctor first.
| DelRicht Research Center | New Orleans, Louisiana, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
| University of Pittsburgh and UPMC Scleroderma Center | Pittsburgh, Pennsylvania, United States | Recruiting |
| Vanderbilt University Medical Center | Nashville, Tennessee, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06675344